Jointown Pharmaceutical Group Co., Ltd (600998.SS)
CNY 5.41
(3.24%)
CNY 5.41
(3.24%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 2.17 Billion CNY | 4.27% |
| 2022 | 2.08 Billion CNY | -14.84% |
| 2021 | 2.44 Billion CNY | -20.38% |
| 2020 | 3.07 Billion CNY | 78.1% |
| 2019 | 1.72 Billion CNY | 28.79% |
| 2018 | 1.34 Billion CNY | -7.26% |
| 2017 | 1.44 Billion CNY | 64.87% |
| 2016 | 876.74 Million CNY | 26.23% |
| 2015 | 694.53 Million CNY | 23.87% |
| 2014 | 560.7 Million CNY | 17.32% |
| 2013 | 477.92 Million CNY | 15.8% |
| 2012 | 412.72 Million CNY | 10.31% |
| 2011 | 374.13 Million CNY | 5.86% |
| 2010 | 353.42 Million CNY | 18.64% |
| 2009 | 297.89 Million CNY | 47.01% |
| 2008 | 202.63 Million CNY | 26.82% |
| 2007 | 159.78 Million CNY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | 669.96 Million CNY | 24.6% |
| 2024 Q3 | 488.54 Million CNY | -27.08% |
| 2024 Q1 | 537.67 Million CNY | 53.46% |
| 2023 Q1 | 561.17 Million CNY | 62.07% |
| 2023 Q3 | 480.68 Million CNY | -38.52% |
| 2023 FY | 2.17 Billion CNY | 4.27% |
| 2023 Q4 | 350.36 Million CNY | -27.11% |
| 2023 Q2 | 781.82 Million CNY | 39.32% |
| 2022 Q3 | 469.69 Million CNY | -42.49% |
| 2022 FY | 2.08 Billion CNY | -14.84% |
| 2022 Q4 | 346.25 Million CNY | -26.28% |
| 2022 Q1 | 452.32 Million CNY | 939.78% |
| 2022 Q2 | 816.69 Million CNY | 80.55% |
| 2021 Q3 | 232.67 Million CNY | -83.52% |
| 2021 Q4 | 43.5 Million CNY | -81.3% |
| 2021 FY | 2.44 Billion CNY | -20.38% |
| 2021 Q1 | 760.01 Million CNY | -18.61% |
| 2021 Q2 | 1.41 Billion CNY | 85.8% |
| 2020 Q3 | 882.43 Million CNY | 29.41% |
| 2020 Q2 | 681.87 Million CNY | 18.18% |
| 2020 Q1 | 576.96 Million CNY | -18.51% |
| 2020 Q4 | 933.77 Million CNY | 5.82% |
| 2020 FY | 3.07 Billion CNY | 78.1% |
| 2019 Q1 | 327.29 Million CNY | -42.5% |
| 2019 Q2 | 415.88 Million CNY | 27.07% |
| 2019 FY | 1.72 Billion CNY | 28.79% |
| 2019 Q3 | 275.38 Million CNY | -33.78% |
| 2019 Q4 | 707.99 Million CNY | 157.09% |
| 2018 Q2 | 315.26 Million CNY | 42.35% |
| 2018 FY | 1.34 Billion CNY | -7.26% |
| 2018 Q4 | 569.21 Million CNY | 142.61% |
| 2018 Q1 | 221.47 Million CNY | -54.86% |
| 2018 Q3 | 234.62 Million CNY | -25.58% |
| 2017 Q2 | 607.18 Million CNY | 226.8% |
| 2017 FY | 1.44 Billion CNY | 64.87% |
| 2017 Q4 | 490.59 Million CNY | 202.96% |
| 2017 Q3 | 161.93 Million CNY | -73.33% |
| 2017 Q1 | 185.79 Million CNY | -55.7% |
| 2016 Q4 | 419.36 Million CNY | 184.73% |
| 2016 FY | 876.74 Million CNY | 26.23% |
| 2016 Q1 | 141.49 Million CNY | -55.67% |
| 2016 Q2 | 168.59 Million CNY | 19.15% |
| 2016 Q3 | 147.28 Million CNY | -12.64% |
| 2015 FY | 694.53 Million CNY | 23.87% |
| 2015 Q4 | 319.21 Million CNY | 155.86% |
| 2015 Q3 | 124.76 Million CNY | -5.51% |
| 2015 Q2 | 132.03 Million CNY | 11.4% |
| 2015 Q1 | 118.52 Million CNY | -55.27% |
| 2014 Q3 | 86.76 Million CNY | -9.7% |
| 2014 Q2 | 96.09 Million CNY | -14.86% |
| 2014 Q1 | 112.87 Million CNY | -52.36% |
| 2014 FY | 560.7 Million CNY | 17.32% |
| 2014 Q4 | 264.97 Million CNY | 205.38% |
| 2013 FY | 477.92 Million CNY | 15.8% |
| 2013 Q1 | 97.79 Million CNY | -56.23% |
| 2013 Q4 | 236.91 Million CNY | 274.12% |
| 2013 Q2 | 79.89 Million CNY | -18.31% |
| 2013 Q3 | 63.32 Million CNY | -20.74% |
| 2012 FY | 412.72 Million CNY | 10.31% |
| 2012 Q4 | 223.45 Million CNY | 447.28% |
| 2012 Q3 | 40.83 Million CNY | -37.26% |
| 2012 Q1 | 83.35 Million CNY | -60.95% |
| 2012 Q2 | 65.07 Million CNY | -21.92% |
| 2011 Q1 | 72.71 Million CNY | -62.98% |
| 2011 Q3 | 34.32 Million CNY | -37.0% |
| 2011 FY | 374.13 Million CNY | 5.86% |
| 2011 Q2 | 54.48 Million CNY | -25.07% |
| 2011 Q4 | 213.44 Million CNY | 521.84% |
| 2010 Q1 | 61.55 Million CNY | 0.0% |
| 2010 Q3 | 39.44 Million CNY | -26.55% |
| 2010 Q4 | 196.4 Million CNY | 397.87% |
| 2010 FY | 353.42 Million CNY | 18.64% |
| 2010 Q2 | 53.71 Million CNY | -12.74% |
| 2009 FY | 297.89 Million CNY | 47.01% |
| 2008 FY | 202.63 Million CNY | 26.82% |
| 2007 FY | 159.78 Million CNY | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Shanghai No.1 Pharmacy Co., Ltd. | 89.27 Million CNY | -2335.214% |
| LBX Pharmacy Chain Joint Stock Company | 929.02 Million CNY | -134.014% |
| Yifeng Pharmacy Chain Co., Ltd. | 1.41 Billion CNY | -53.971% |
| Yunnan Jianzhijia Health-Chain Co., Ltd. | 414.41 Million CNY | -424.61% |